Non-competitive inhibition by active site binders.
Reads0
Chats0
TLDR
Tools like alternative substrates, testing the enzyme reaction in the reverse direction and monitoring inhibition time dependence can be applied to enable distinction between ‘badly behaving’ active site binders and true exosite inhibitors.Abstract:
Classical enzymology has been used for generations to understand the interactions of inhibitors with their enzyme targets. Enzymology tools enabled prediction of the biological impact of inhibitors as well as the development of novel, more potent, ones. Experiments designed to examine the competition between the tested inhibitor and the enzyme substrate(s) are the tool of choice to identify inhibitors that bind in the active site. Competition between an inhibitor and a substrate is considered a strong evidence for binding of the inhibitor in the active site, while the lack of competition suggests binding to an alternative site. Nevertheless, exceptions to this notion do exist. Active site-binding inhibitors can display non-competitive inhibition patterns. This unusual behavior has been observed with enzymes utilizing an exosite for substrate binding, isomechanism enzymes, enzymes with multiple substrates and/or products and two-step binding inhibitors. In many of these cases, the mechanisms underlying the lack of competition between the substrate and the inhibitor are well understood. Tools like alternative substrates, testing the enzyme reaction in the reverse direction and monitoring inhibition time dependence can be applied to enable distinction between 'badly behaving' active site binders and true exosite inhibitors.read more
Citations
More filters
Journal ArticleDOI
SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition
Nadia J. Kershaw,James M. Murphy,James M. Murphy,Nicholas P. D. Liau,Nicholas P. D. Liau,Leila N. Varghese,Leila N. Varghese,Artem Laktyushin,Eden L Whitlock,Isabelle S Lucet,Nicos A. Nicola,Nicos A. Nicola,Jeffrey J. Babon,Jeffrey J. Babon +13 more
TL;DR: In this article, the crystal structure of SOCS3 bound to JAK2 and a fragment of the interleulkin-6 receptor reveals how it exerts its inhibitory activity by blocking substrate binding.
Journal ArticleDOI
Ethylene signaling in plants
TL;DR: Although this canonical pathway is the predominant signaling cascade, alternative pathways also affect ethylene responses, and this review summarizes the current understanding of ethylene signaling, including these alternative pathways, and discusses how Ethylene signaling has been manipulated for agricultural and horticultural applications.
Journal ArticleDOI
Inhibitors of Protein Methyltransferases and Demethylases.
TL;DR: This review covers the discovery, characterization, and biological application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field and discusses challenges, opportunities, and future directions in this emerging, exciting research field.
Journal ArticleDOI
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
Mohammad S. Eram,Yudao Shen,Magdalena M. Szewczyk,Hong Wu,Guillermo Senisterra,Fengling Li,Kyle V. Butler,H. Uemit Kaniskan,Brandon A. Speed,Carlo C. dela Seña,Aiping Dong,Hong Zeng,Matthieu Schapira,Matthieu Schapira,Peter Brown,Cheryl H. Arrowsmith,Cheryl H. Arrowsmith,Dalia Barsyte-Lovejoy,Jing Liu,Masoud Vedadi,Masoud Vedadi,Jian Jin +21 more
TL;DR: The discovery of a potent, selective, and cell-active inhibitor of human type I PRMTs, MS023, and characterization of this inhibitor in a battery of biochemical, biophysical, and cellular assays are reported.
Journal ArticleDOI
Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice.
Jessica Vincent,Carolina Adura,Pu Gao,Pu Gao,Antonio Luz,Antonio Luz,L. Lama,L. Lama,Asano Yasutomi,Rei Okamoto,Toshihiro Imaeda,Aida Jumpei,Katherine Rothamel,Tasos Gogakos,Tasos Gogakos,Joshua Steinberg,Joshua Steinberg,Seth A. Reasoner,Kazuyoshi Aso,Thomas Tuschl,Thomas Tuschl,Dinshaw J. Patel,J. Fraser Glickman,Manuel Ascano +23 more
TL;DR: It is found that a chemically improved member, RU.521, is active and selective in cellular assays of cyclic GMP-AMP synthase-mediated signaling and reduces constitutive expression of interferon in macrophages from a mouse model of Aicardi-Goutières syndrome.
References
More filters
Book
Enzymes : a practical introduction to structure, mechanism, and data analysis
TL;DR: This paper presents a meta-analyses of Enzyme Reactions with Multiple Substrates with the aim of determining the mechanism behind Cooperativity in Enzyme Catalysis and its role in enzymology.
Journal ArticleDOI
Features of Selective Kinase Inhibitors
TL;DR: Some of the features that determine the cellular activity of kinase inhibitors are discussed and a framework for interpreting inhibitor selectivity is proposed.
Journal ArticleDOI
Residence time of receptor-ligand complexes and its effect on biological function.
TL;DR: The impact of residence time on the optimization of potential ligands as drugs for human medicine is described and its significance to biological function is described.
Journal ArticleDOI
The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0.
Wolfram Bode,Peter Schwager +1 more
TL;DR: The crystal structure of benzamidine-inhibited bovine β -trypsin has been refined by constrained crystallographic refinement at 1·8 A resolution and led to the finding of a single site occupied by calcium.
Journal ArticleDOI
Crystal Structure of Hck in Complex with a Src Family–Selective Tyrosine Kinase Inhibitor
Thomas Schindler,Frank Sicheri,Alexander R. Pico,Aviv Gazit,Alexander Levitzki,John Kuriyan,John Kuriyan +6 more
TL;DR: The enlargement of this pocket in autoinhibited Src kinases suggests a route toward the development of inhibitors that are specific for the inactive forms of these proteins.
Related Papers (5)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre,Kristy G Kuplast,Christina R. Majer,P. Ann Boriack-Sjodin,Tim J. Wigle,L. Danielle Johnston,Nathalie Rioux,Michael John Munchhof,Lei Jin,Suzanne L. Jacques,Kip A West,Trupti Lingaraj,Kimberly Stickland,Scott Ribich,Alejandra Raimondi,Margaret Porter Scott,Nigel J. Waters,Roy M. Pollock,J. Joshua Smith,Olena Barbash,Melissa B. Pappalardi,Thau F. Ho,Kelvin Nurse,Khyati P Oza,Kathleen T. Gallagher,Ryan G. Kruger,Mikel P. Moyer,Robert A. Copeland,Richard Chesworth,Kenneth W. Duncan +29 more
Phenix - a comprehensive python-based system for macromolecular structure solution
Paul D. Adams,Paul D. Adams,Pavel V. Afonine,Gábor Bunkóczi,Vincent B. Chen,Ian W. Davis,Nathaniel Echols,Jeffrey J. Headd,Li-Wei Hung,Gary J. Kapral,Ralf W. Grosse-Kunstleve,Airlie J. McCoy,Nigel W. Moriarty,Robert D. Oeffner,Randy J. Read,David S. Richardson,Jane S. Richardson,Thomas C. Terwilliger,Peter H. Zwart +18 more